Crosslinks has produced a robust diagnostic analysis platform in collaboration with Skyline Diagnostics to deliver a state-of-the-art microarray-based prognoses for Acute Myeloid Leukaemia (AML) patients. The system enables speedy and accurate identification of Leukaemia sub-types so that the most effective subtype-specific treatments read more »

The identification by omics technologies of prognostic markers to predict colorectal cancer behavior and response to treatment especially as far as liver metastasis is concerned. Objectives are to collect clinical data from patients with colorectal cancer. Organize regional follow-up regimen for diagnosing local read more »

HiPerDART is an EU funded project project aiming to develop a higher standard (clinical) microarray technology platform, by using an innovative probe printing technology called Supramolecular NanoStamping (SuNS). Crosslinks’ role within the project is to perform quality control measurements to ensure they read more »